Spire Wealth Management Viracta Therapeutics, Inc. Transaction History

Spire Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$1.87 - $5.0 $265 - $710	142 New	142 $1,000
Q1 2022 Apr 18, 2022	SELL	$2.23 - $4.76 $3,182 - $6,792	-1,427 Closed	0 $0
Q4 2021 Jan 14, 2022	SELL	$3.37 - $7.91 $7,653 - $17,963	-2,271 Reduced 61.41%	1,427 $5,000
Q3 2021 Oct 22, 2021	SELL	$7.84 - $12.53 $26,852 - $42,915	-3,425 Reduced 48.08%	3,698 $30,000
Q2 2021 Jul 26, 2021	BUY	$7.55 - $12.95 $37,010 - $63,480	4,902 Added 220.71%	7,123 $81,000
Q1 2021 May 21, 2021	BUY	$7.58 - $18.67 $16,835 - $41,466	2,221 New	2,221 $21,000

5.63M

Ticker VIRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,558,200
Market Cap $9.39M
Description
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.